Complications œsophagiennes des médicaments anti-inflammatoires non stéroïdiens

Vane, 1971, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nat New Biol, 231, 232, 10.1038/newbio231232a0 Goyal, 1973, Mechanism of the lower esophageal sphincter relaxation, J Clin Invest, 52, 337, 10.1172/JCI107189 Mukhopadhyay, 1975, Effect of prostaglandin E2 on esophageal motility in man, J Appl Physiol, 39, 479, 10.1152/jappl.1975.39.3.479 Eastwood, 1981, Beneficial effect of indomethacin on acid-induced esophagitis in cats, Dig Dis Sci, 26, 601, 10.1007/BF01367672 Sarosiek, 1994, Impact of acid and pepsin on human esophageal prostaglandins, Am J Gastroenterol, 89, 588 Sarosiek, 1995, Esophagoprotection by prostaglandins: how far are we from reaching the verdict?, Am J Gastroenterol, 90, 847 Lanas, 1995, Aspirin renders the esophageal mucosa more permeable to acid and pepsin, Eur J Gastroenterol Hepatol, 7, 1065, 10.1097/00042737-199511000-00009 Lanas, 1997, Adaptation of esophageal mucosa to acid and pepsin-induced damage. Role of nitric oxide and epidermal growth factor, Dig Dis Sci, 42, 1003, 10.1023/A:1018837003196 Scheiman, 1995, Effect of naproxen on gastroesophageal reflux and esophageal function: a randomized, double-blind, placebo-controlled study, Am J Gastroenterol, 90, 754 Sopena, 1998, Esophageal motility and intraesophageal pH patterns in patients with esophagitis and chronic nonsteroidal anti-inflammatory drug use, J Clin Gastroenterol, 27, 316, 10.1097/00004836-199812000-00007 Cryer, 2000, Effects of non-steroidal anti-inflammatory drugs (NSAIDS) on a acid reflux in patients with gastroesophageal reflux disease (GERD) (abstract), Gastroenterology, 118, A862, 10.1016/S0016-5085(00)85589-4 Talley, 1995, Nonsteroidal antinflammatory drugs and dyspepsia in the elderly, Dig Dis Sci, 40, 1345, 10.1007/BF02065549 Voutilainen, 2000, Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms, Digestion, 61, 6, 10.1159/000007730 Kotzan, 2001, Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a medicaid population, Pharmaceutical Research, 18, 1967, 10.1023/A:1013010616496 Yeomans, 2003, Esomeprazole provides effective control of NSAID-associated upper GI symptoms in patients continuing to take NSAIDs (abstract), Gastroenterology, 124, A107, 10.1016/S0016-5085(03)80527-9 Semble, 1989, Nonsteroidal antinflammatory drugs and esophageal injury, Seminars in arthritis and rheumatism, 19, 99, 10.1016/0049-0172(89)90054-1 Avidan, 2001, Risk factors of esophagitis in arthritic patients, Eur J Gastroenterol Hepatol, 13, 1095, 10.1097/00042737-200109000-00017 Taha, 1994, Oesophageal histology in long term users of non-steroidal antiinflammatory drugs, J Clin Pathol, 47, 705, 10.1136/jcp.47.8.705 El-Serag, 1997, Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs, Am J Gastroenterol, 92, 52 Simon, 1999, Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis. A randomized controlled trial, JAMA, 282, 1921, 10.1001/jama.282.20.1921 Laine, 1999, A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis, Gastroenterology, 117, 776, 10.1016/S0016-5085(99)70334-3 Hawkey, 2000, Comparison of the effect of rofecoxib (a cyclooxygenase-2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis. A randomized, double-blind, placebo-controlled trial, Arthritis and rheumatism, 43, 370, 10.1002/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D Silverstein, 2000, Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs of osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized controlled trial, JAMA, 284, 1247, 10.1001/jama.284.10.1247 Heller, 1982, Non-steroidal anti-inflammatory drugs and benign oesophageal stricture, Br Med J, 285, 167, 10.1136/bmj.285.6336.167 Wilkins, 1984, Benign stricture of the oesophagus: role of non-steroidal anti-inflammatory drugs, Gut, 25, 478, 10.1136/gut.25.5.478 Bellary, 1991, Upper gastrointestinal lesions in elderly patients presenting for endoscopy: relevance of NSAID usage, Am J Gastroenterol, 86, 961 Kim, 1999, NSAIDS, aspirin and esophageal strictures: are over-the-counter medications harmful to the esophagus?, J Clin Gastroenterol, 29, 32, 10.1097/00004836-199907000-00008 Kikendall, 1999, Pill esophagitis, J Clin Gastroenterol, 28, 298, 10.1097/00004836-199906000-00004 Levine, 1994, Esophageal stricture caused by a Motrin tablet (ibuprofen), Abdom Imaging, 19, 6, 10.1007/BF02165851 Nicolopoulos, 1985, Prophylactic administration of indomethacin for irradiation esophagitis, Radiother Oncol, 3, 23, 10.1016/S0167-8140(85)80005-0 Buttar, 2002, Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus, Gastroenterology, 122, 1101, 10.1053/gast.2002.32371 Ledinghen, 1996, Non-steroidal anti-inflammatory drugs and variceal bleeding: a case-control study, J Hepatol, 24, 570, 10.1016/S0168-8278(96)80142-5 Ledinghen, 1999, Anti-inflammatory drugs and variceal bleeding: a case-control study, Gut, 44, 270, 10.1136/gut.44.2.270